• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于检测血浆中华法林、达比加群、利伐沙班、阿哌沙班、未分级肝素和依诺肝素的单项检测。

A single test to assay warfarin, dabigatran, rivaroxaban, apixaban, unfractionated heparin, and enoxaparin in plasma.

机构信息

Landspitali The National University Hospital of Iceland, Reykjavik, Iceland.

University of Rochester Medical Center, Rochester, NY, USA.

出版信息

J Thromb Haemost. 2016 May;14(5):1043-53. doi: 10.1111/jth.13300. Epub 2016 Mar 30.

DOI:10.1111/jth.13300
PMID:26924677
Abstract

UNLABELLED

Essentials Simple and fast assaying of different anticoagulants (ACs) is useful in emergent situations. We used highly diluted prothrombin time (dPT) or highly diluted Fiix-PT (dFiix-PT) to assay ACs. Both tests could quantify target specific anticoagulants and warfarin anticoagulation. Improved results were consistently observed with the dFiix-PT compared with the dPT.

SUMMARY

Background Assaying anticoagulants is useful in emergency situations or before surgery. Different specific assays are currently needed depending on the anticoagulant. Objectives We hypothesized that levels of warfarin, dabigatran, rivaroxaban, apixaban, and heparins could be measured with use of the diluted prothrombin time (dPT) and diluted Fiix-PT (dFiix-PT), using highly diluted thromboplastin (TP). The latter test is affected only by reduced levels of active factors II and X but corrects test plasma for other deficiencies Methods Increasing TP dilutions were used to identify suitable dilutions to measure dabigatran, rivaroxaban, apixaban, unfractionated heparin (UFH), and enoxaparin. Calibrators containing known amounts of direct oral anticoagulants (DOACs) were used to make standard curves. Citrated plasma samples were obtained from patients taking warfarin or DOACs with known drug concentrations as determined by specific assays. Results The dFiix-PT at a TP dilution of 1:1156 could be used to measure all of the drugs tested at therapeutic concentrations except for fondaparinux. The dPT achieved the same but required two TP dilutions (1:750 and 1:300). The warfarin effect could be assessed by using dFiix-PT at 1:1156 with a PT ratio identical to the international normalized ratio. Six different TPs yielded similar results, but two were less sensitive. Dabigatran, rivaroxaban, and apixaban could be accurately measured in patient samples using both dilute PT assays, but a better correlation was consistently observed between the dFiix-PT and specific assays than with the dPT. Conclusion The dFiix-PT using a single dilution of TP may be suitable to assess the anticoagulant effects of warfarin, dabigatran, rivaroxaban, apixaban, heparin, and enoxaparin.

摘要

目的

检测不同抗凝剂(ACs)在紧急情况下或手术前非常有用。目前,不同的抗凝剂需要不同的特定检测方法。

方法

我们使用高度稀释的凝血酶原时间(dPT)或高度稀释的 Fiix-PT(dFiix-PT)检测 ACs。这两种检测方法都可以定量检测目标特异性抗凝剂和华法林抗凝。与 dPT 相比,dFiix-PT 始终能获得更好的结果。

结果

在 1:1156 的高度稀释 TP 下,dFiix-PT 可用于测量所有在治疗浓度下测试的药物,除了达比加群酯。dPT 也能达到同样的效果,但需要两种 TP 稀释(1:750 和 1:300)。dFiix-PT 在 1:1156 下可以评估华法林的抗凝效果,PT 比值与国际标准化比值相同。使用六种不同的 TP 得到了相似的结果,但其中两种敏感性较低。在患者样本中,两种稀释 PT 检测方法都可以准确测量达比加群酯、利伐沙班和阿哌沙班,但 dFiix-PT 与特定检测方法之间的相关性始终优于 dPT。

结论

单一稀释 TP 的 dFiix-PT 可能适用于评估华法林、达比加群酯、利伐沙班、阿哌沙班、肝素和依诺肝素的抗凝效果。

相似文献

1
A single test to assay warfarin, dabigatran, rivaroxaban, apixaban, unfractionated heparin, and enoxaparin in plasma.一种用于检测血浆中华法林、达比加群、利伐沙班、阿哌沙班、未分级肝素和依诺肝素的单项检测。
J Thromb Haemost. 2016 May;14(5):1043-53. doi: 10.1111/jth.13300. Epub 2016 Mar 30.
2
Interlaboratory variability in the measurement of direct oral anticoagulants: results from the external quality assessment scheme.实验室间直接口服抗凝剂测量的变异性:来自外部质量评估计划的结果。
J Thromb Haemost. 2018 Mar;16(3):565-570. doi: 10.1111/jth.13949. Epub 2018 Jan 29.
3
Direct oral anticoagulants and heparins: laboratory values and pitfalls in 'bridging therapy'.直接口服抗凝剂与肝素:实验室检查值及“桥接治疗”中的陷阱
Eur J Cardiothorac Surg. 2017 Apr 1;51(4):624-632. doi: 10.1093/ejcts/ezw368.
4
Poor comparability of coagulation screening test with specific measurement in patients receiving direct oral anticoagulants: results from a multicenter/multiplatform study.在接受直接口服抗凝剂治疗的患者中,凝血筛选试验与特定检测方法的可比性较差:一项多中心/多平台研究的结果。
J Thromb Haemost. 2016 Nov;14(11):2194-2201. doi: 10.1111/jth.13486. Epub 2016 Oct 15.
5
Sensitivity of routine coagulation assays to direct oral anticoagulants: patient samples versus commercial drug-specific calibrators.常规凝血检测对直接口服抗凝剂的敏感性:患者样本与商业药物特异性校准物的比较。
Pathology. 2016 Dec;48(7):712-719. doi: 10.1016/j.pathol.2016.07.008. Epub 2016 Oct 22.
6
A simple and fast HPLC-MS/MS method for simultaneous determination of direct oral anticoagulants apixaban, dabigatran, rivaroxaban in human plasma.一种简单、快速的 HPLC-MS/MS 法同时测定人血浆中的直接口服抗凝药阿哌沙班、达比加群、利伐沙班。
J Chromatogr B Analyt Technol Biomed Life Sci. 2018 Nov 15;1100-1101:43-49. doi: 10.1016/j.jchromb.2018.09.026. Epub 2018 Sep 27.
7
Evaluation of dabigatran, rivaroxaban and apixaban target-specific assays in a multicenter French study.多中心法国研究中达比加群、利伐沙班和阿哌沙班靶特异性检测方法的评估。
Thromb Res. 2017 Oct;158:126-133. doi: 10.1016/j.thromres.2017.09.001. Epub 2017 Sep 4.
8
Bleeding with dabigatran, rivaroxaban, apixaban. No antidote, and little clinical experience.达比加群、利伐沙班、阿哌沙班引起的出血。无解毒剂,临床经验也少。
Prescrire Int. 2013 Jun;22(139):155-9.
9
Effects of direct oral anticoagulants on lupus anticoagulant assays in a real-life setting.直接口服抗凝剂对真实环境中狼疮抗凝物检测的影响。
Thromb Haemost. 2017 Aug 30;117(9):1700-1704. doi: 10.1160/TH17-03-0204. Epub 2017 Jun 22.
10
Quantitation of the Oral Anticoagulants Dabigatran, Rivaroxaban, Apixaban, and Warfarin in Plasma Using Ultra-Performance Liquid Chromatography with Tandem Mass Spectrometry (UPLC-MS/MS).采用超高效液相色谱-串联质谱法(UPLC-MS/MS)对血浆中口服抗凝剂达比加群、利伐沙班、阿哌沙班和华法林进行定量分析。
Methods Mol Biol. 2016;1383:21-7. doi: 10.1007/978-1-4939-3252-8_3.

引用本文的文献

1
Clot time ratio (CTR) and treatment outcomes in Apixaban-treated atrial fibrillation patients.阿哌沙班治疗的心房颤动患者的凝块时间比值(CTR)和治疗结果。
Sci Rep. 2024 Mar 21;14(1):6831. doi: 10.1038/s41598-024-57648-0.
2
Hemostasis and Thrombosis: An Overview Focusing on Associated Laboratory Testing to Diagnose and Help Manage Related Disorders.止血与血栓形成:概述,重点介绍相关实验室检测,以诊断和帮助管理相关疾病。
Methods Mol Biol. 2023;2663:3-38. doi: 10.1007/978-1-0716-3175-1_1.
3
Replacement of traditional prothrombin time monitoring with the new Fiix prothrombin time increases the efficacy of warfarin without increasing bleeding. A review article.
用新型Fiix凝血酶原时间监测取代传统凝血酶原时间监测可提高华法林疗效且不增加出血风险。一篇综述文章。
Thromb J. 2021 Oct 15;19(1):72. doi: 10.1186/s12959-021-00327-1.
4
Updates on Anticoagulation and Laboratory Tools for Therapy Monitoring of Heparin, Vitamin K Antagonists and Direct Oral Anticoagulants.肝素、维生素K拮抗剂及直接口服抗凝剂抗凝治疗进展与实验室监测工具
Biomedicines. 2021 Mar 7;9(3):264. doi: 10.3390/biomedicines9030264.
5
Detecting clinically relevant rivaroxaban or dabigatran levels by routine coagulation tests or thromboelastography in a cohort of patients with atrial fibrillation.在一组房颤患者中,通过常规凝血试验或血栓弹力图检测具有临床相关性的利伐沙班或达比加群水平。
Thromb J. 2018 Feb 1;16:3. doi: 10.1186/s12959-017-0160-2. eCollection 2018.
6
Practical guidance on the use of laboratory testing in the management of bleeding in patients receiving direct oral anticoagulants.关于在接受直接口服抗凝剂治疗的患者出血管理中使用实验室检测的实用指南。
Vasc Health Risk Manag. 2017 Dec 13;13:457-467. doi: 10.2147/VHRM.S126265. eCollection 2017.